IL2 and type 1 diabetes mellitus: In summary, the impact of ld-IL-2 on the endogenous and infused Tregs populations in the TILT study was similar as compared with other clinical trials treating patients with T1D with ld-IL-2, and no evidence links those changes to a less functional Treg compartment.